Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...
Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...
(Bloomberg) -- Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the ...
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 46% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-two (52%) disapprove. The latest figures ...